The Changing Definition of Contrast-Induced Nephropathy and Its Clinical Implications: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Study Questions:

What is the sensitivity, specificity, and clinical implication of using a ≥25% increase from baseline creatinine, on contrast-induced nephropathy (CIN) detection?